Atossa Therapeutics, Inc. Common Stock ATOS
$2.79
+7.31%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $20.33
- Implied Upside
- +628.8%
- Price Target Range
- $12.00 – $25.00
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-07 | Rodman & RenshawMichael G. King Jr. |
Initiates coverage on | Buy | $12 |
| 2026-04-10 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $120 → $24 |
| 2026-03-26 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $7 → $25 |
| 2025-12-08 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $8 → $8 |
| 2025-09-22 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $8 → $8 |
| 2025-06-06 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $7 → $8 |
| 2025-06-05 | Craig-HallumAlbert Lowe |
Initiates coverage on | Buy | $4 |
| 2025-04-21 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $7 → $7 |
| 2025-03-26 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $7 |
| 2025-03-12 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $7 |
| 2025-01-30 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $7 |
| 2024-12-13 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $7 |
| 2024-12-12 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | — |
| 2024-12-09 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $7 → $7 |
| 2024-11-13 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $6 → $7 |
| 2024-11-05 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $6 |
| 2024-10-31 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $6 |
| 2024-09-11 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $6 → $7 |
| 2024-08-12 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $6 |
| 2024-06-28 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $6 |
| 2024-06-20 | Cantor FitzgeraldLouise Chen |
Reiterates | Overweight | — |
| 2024-06-06 | Ascendiant CapitalEdward Woo |
Maintains | Buy | $6 → $6 |
| 2024-05-14 | Cantor FitzgeraldLouise Chen |
Reiterates | Overweight | — |
| 2024-05-13 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $4 → $6 |
| 2024-04-16 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $4 |
| 2024-04-02 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $4 |
| 2024-02-12 | HC Wainwright & Co.Emily Bodnar |
Initiates coverage on | Buy | $4 |
| 2023-09-08 | Cantor FitzgeraldLouise Chen |
Initiates coverage on | Overweight | $5 |
| 2020-09-17 | Ascendiant Capital |
Initiates coverage on | Buy | $7 |
| 2019-12-18 | Maxim GroupJason McCarthy |
Upgrades | Hold → Buy | — |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $2.79
- Market Cap
- $25.95 million
- 52-Week Range
- $1.70 – $19.35
- Average Volume
- 87K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.